Stock Events

Stock Events

Arch Therapeutics

$0.18

2

+$0+0% Friday 19:05

Statistics

Day High

0.19

Day Low

0.18

52W High

0.8

52W Low

0.18

Volume

6,600

Avg. Volume

1

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

1JanExpected

Q4 0

82

82.33

82.67

83

Expected EPS

82

Actual EPS

N/A

Financials

-9,188.16%Profit Margin

Unprofitable

2018

2019

2020

2021

2022

2023

76,000Revenue

-6.98MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0HHJ.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Johnson & Johnson

Johnson & Johnson operates in the medical devices segment, offering products that could compete with Arch's surgical and wound care solutions.

Medtronic offers advanced wound care and surgical solutions, directly competing with Arch Therapeutics' product offerings.

Boston Scientific

Boston Scientific Corporation provides medical solutions that could be used in similar applications as Arch's, particularly in surgical environments.

Stryker Corporation specializes in medical and surgical equipment, posing competition to Arch's surgical products and technologies.

Baxter International

Baxter International Inc. offers advanced recovery and care products, competing in the wound care and surgical product market.

Abbott Laboratories

Abbott Laboratories has a broad range of medical devices and health care solutions that could compete with Arch Therapeutics' offerings.

Zimmer Biomet Holdings, Inc. provides solutions in musculoskeletal healthcare, which may overlap with Arch's surgical and wound care technologies.

Intuitive Surgical

Intuitive Surgical, Inc. offers robotic-assisted surgical systems, potentially competing with Arch's approach to improving surgical outcomes.

Cooper Companies

The Cooper Companies operate in medical device sector, offering products that could compete in the surgical and wound care space.

West Pharmaceutical Services

West Pharmaceutical Services, Inc. provides innovative solutions for injectable drug administration, indirectly competing with Arch's technology in terms of delivery and therapeutic outcomes.

About

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. The company was founded in 2006 and is based in Framingham, Massachusetts.

Show more...

CEO

Employees

10

Country

United States

ISIN

US03939W2089

Listings

0 Comments

Share your thoughts

FAQ

What is Arch Therapeutics stock price today?▼

The current price of 0HHJ.LSE is $0.18 USD — it has increased by +0% in the past 24 hours. Watch Arch Therapeutics stock price performance more closely on the chart.

What is Arch Therapeutics stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Arch Therapeutics stocks are traded under the ticker 0HHJ.LSE.

What is Arch Therapeutics revenue for the last year?▼

Arch Therapeutics revenue for the last year amounts to 76,000 USD.

What is Arch Therapeutics net income for the last year?▼

0HHJ.LSE net income for the last year is -6.98M USD.

How many employees does Arch Therapeutics have?▼

As of May 05, 2026, the company has 10 employees.

In which sector is Arch Therapeutics located?▼

Arch Therapeutics operates in the Energy sector.

When did Arch Therapeutics complete a stock split?▼

The last stock split for Arch Therapeutics was on January 18, 2023 with a ratio of 1:200.